von Tobias Borgers | Aug. 23, 2022 | Continuous Manufacturing
Developments in manufacturing processes for advanced therapiesAdvanced therapy medicinal products (ATMPs) comprise a new category of medicines for humans and are based on biological materials such as genes, cells, or tissues.1 It is essential to minimize losses of...
von Tobias Borgers | Juli 5, 2022 | Continuous Manufacturing
Automation and digitalization work together in the digital plant.Automation—using machines rather than people to perform tasks—offers benefits to biopharmaceutical manufacturers in multiple facets of plant operation, such as transporting materials, taking samples, and...
von Tobias Borgers | Juni 21, 2022 | Continuous Manufacturing
Sirona Biochem Inc. (TSXV:SBM) is a biotechnology company with an innovative platform for developing safer, more effective cosmetic and pharmaceutical active ingredients. The technology is based on proprietary fluorination chemistry developed by the company’s...
von Tobias Borgers | Juni 21, 2022 | Continuous Manufacturing
Digital transformation is a major undertaking for any manufacturer. But factor in the mission critical, highly regulated, and quality-conscious nature of pharmaceutical production and the effort becomes even more daunting.Pharma 4.0 is a maturity model-based framework...
von Tobias Borgers | Juni 21, 2022 | Continuous Manufacturing
$111 Million Equity Investment Round to Support Continued Development and Deployment of ApiJect’s Proprietary High-Volume Manufacturing Platform for Single-Dose Prefilled Injection Devices. STAMFORD, Conn., May 18, 2022 /PRNewswire/ — ApiJect Holdings,...
von Tobias Borgers | Juni 13, 2022 | Continuous Manufacturing
In the future, Susan Lang believes that 3D printing could be a distributed technology, allowing localised small-batch printing when a medication is needed. XIL Health founder and CEO Susan Lang believes that 3D-printed drugs are poised to be the future of...
